Associations between Nitric Oxide Synthase Genes and Exhaled NO-Related Phenotypes according to Asthma Status

Background The nitric oxide (NO) pathway is involved in asthma, and eosinophils participate in the regulation of the NO pool in pulmonary tissues. We investigated associations between single nucleotide polymorphisms (SNPs) of NO synthase genes (NOS) and biological NO-related phenotypes measured in two compartments (exhaled breath condensate and plasma) and blood eosinophil counts. Methodology SNPs (N = 121) belonging to NOS1, NOS2 and NOS3 genes were genotyped in 1277 adults from the French Epidemiological study on the Genetics and Environment of Asthma (EGEA). Association analyses were conducted on four quantitative phenotypes: the exhaled fraction of NO (Fe NO), plasma and exhaled breath condensate (EBC) nitrite-nitrate levels (NO2–NO3) and blood eosinophils in asthmatics and non-asthmatics separately. Genetic heterogeneity of these phenotypes between asthmatics and non-asthmatics was also investigated. Principal Findings In non-asthmatics, after correction for multiple comparisons, we found significant associations of FeNO levels with three SNPs in NOS3 and NOS2 (P≤0.002), and of EBC NO2–NO3 level with NOS2 (P = 0.002). In asthmatics, a single significant association was detected between Fe NO levels and one SNP in NOS3 (P = 0.004). Moreover, there was significant heterogeneity of NOS3 SNP effect on FeNO between asthmatics and non-asthmatics (P = 0.0002 to 0.005). No significant association was found between any SNP and NO2–NO3 plasma levels or blood eosinophil counts. Conclusions Variants in NO synthase genes influence FeNO and EBC NO2–NO3 levels in adults. These genetic determinants differ according to asthma status. Significant associations were only detected for exhaled phenotypes, highlighting the critical relevance to have access to specific phenotypes measured in relevant biological fluid.

[1]  Alison J. Montpetit,et al.  Exhaled breath condensate: an overview. , 2007, Immunology and allergy clinics of North America.

[2]  L. Modig,et al.  Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide , 2012, Journal of Medical Genetics.

[3]  S. Erzurum,et al.  Nitric oxide metabolism in asthma pathophysiology. , 2011, Biochimica et biophysica acta.

[4]  Margaret W Leigh,et al.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.

[5]  K. Berhane,et al.  Genetic variations in nitric oxide synthase and arginase influence exhaled nitric oxide levels in children , 2011, Allergy.

[6]  M. Hezel,et al.  Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care , 2010, Anesthesiology.

[7]  Florence Demenais,et al.  A large-scale, consortium-based genomewide association study of asthma. , 2010, The New England journal of medicine.

[8]  C. Giulivi,et al.  Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. , 2010, Free radical biology & medicine.

[9]  J. Bousquet,et al.  Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  C. Peixoto,et al.  Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine. , 2010, American journal of respiratory and critical care medicine.

[11]  E. Weitzberg,et al.  The biological role of nitrate and nitrite: the times they are a-changin'. , 2010, Nitric oxide : biology and chemistry.

[12]  A. Fitzpatrick,et al.  Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. , 2009, The Journal of allergy and clinical immunology.

[13]  P. Gibson,et al.  The overlap syndrome of asthma and COPD: what are its features and how important is it? , 2009, Thorax.

[14]  D. Taylor Risk assessment in asthma and COPD: a potential role for biomarkers? , 2009, Thorax.

[15]  M. Malerba,et al.  Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. , 2008, Chest.

[16]  Mark T. Gladwin,et al.  The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics , 2008, Nature Reviews Drug Discovery.

[17]  J. Batra,et al.  Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels , 2006, Thorax.

[18]  G. Folkerts,et al.  Reactive nitrogen species in the respiratory tract. , 2006, European journal of pharmacology.

[19]  Using Ebc ATS Workshop Proceedings: Exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate: Executive summary. , 2006, American journal of respiratory and critical care medicine.

[20]  G. Abecasis,et al.  Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. , 2005, American journal of human genetics.

[21]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[22]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[23]  S. Holgate,et al.  Nitric oxide , hypoxia , and superoxide : the good , the bad , and the ugly ! , 2005 .

[24]  D. Knight,et al.  Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath , 2004, Thorax.

[25]  L. Palmer,et al.  Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. , 2003, American journal of respiratory and critical care medicine.

[26]  J. Bousquet,et al.  Epidemiologic study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy. , 2002, Chest.

[27]  Q. Hamid,et al.  Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. , 2001, American journal of respiratory and critical care medicine.

[28]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[29]  E. Silverman,et al.  Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. , 2000, American journal of respiratory and critical care medicine.

[30]  J. Bousquet,et al.  EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-- descriptive characteristics. , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[32]  J. Bousquet,et al.  Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. , 1997, American journal of respiratory and critical care medicine.

[33]  V. del Pozo,et al.  Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. , 1997, Journal of immunology.

[34]  P. Jansen,et al.  Nitrite and nitrate determinations in plasma: a critical evaluation. , 1995, Clinical chemistry.

[35]  J. Stamler,et al.  Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S L Zeger,et al.  Regression analysis for correlated data. , 1993, Annual review of public health.

[37]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.